For The Consortium

Clinical Research Management Meetings

Clnical Research Management Workshop Planning Group
December 16, 2008
Meeting Materials  Agenda

Clinical Research Management Key Function Committee
December 12, 2008
Meeting Materials  Agenda
 Meeting Summary

Clinical Research Management Taskforce
October 17, 2008
Meeting Materials  Agenda
 Meeting Summary

Enhancing Clinical Investigation by Improved Clinical Research Management
June 24, 2008
Meeting Materials  Agenda
Presentations
Quality Improvement 
Using Metrics for Quality Improvement
Tesheia H. Johnson, MBA
Chief Operations Officer for Clinical Investigation
Yale University
Process Engineering 
Faculty Perspective: Challenges of Implementing Change
Sara Rockwell, PhD
Director, Office of Scientific Affairs
Yale University School of Medicine
Poster Session 
Atlanta Clinical & Translational Science Institute
Cleveland Clinical and Translational Science Collaborative
Columbia University Medical Center
Duke Translational Medicine Institute
Eli Lilly and Company
Mayo Clinic
Oregon Clinical & Translational Research Institute
The Rockefeller University
The University of Wisconsin-Madison
The Vanderbilt Institute for Clinical and Translational Research
UC Davis Clinical and Translational Science Center
UCSF Clinical and Translational Science Institute
University of Chicago
University of Michigan
University of Pennsylvania
University of Pittsburgh
University of Rochester
University of Washington
Washington University
Weill Cornell Medical College
Yale Center for Clinical Investigation

Enhancing Clinical Investigation by Improved Clinical Research Management
June 23, 2008
Meeting Materials  Agenda
Presentations
NIH Perspective 
NIH View of Clinical Trial Management
Walter J. Koroshetz, MD
Deputy Director
NINDS
Why is Improved Clinical Research Management Important? 
Why is Improved Clinical Research Management Important?
Robert M. Califf, MD
Vice Chancellor for Clinical Research
Director, Duke Translational Medicine Institute
Metrics and Measurements 
Metrics and Measurements, justification, definition, application
Daniel E. Ford, MD, MPH
Vice Dean for Clinical Investigation
Johns Hopkins University
IRB metrics 
IRB and Regulatory, metrics and measurement
Tony Perez
Chief Health Sciences Counsel
University of California, San Diego
Case Presentation 
IRB Metrics, alternative processes
Gary L. Chadwick, PharmD, MPH, CIP
Associate Provost
University of Rochester
Contracts and Grants 
Contract Negotiation Metrics & Measurements
James A. Moran JD, CPA
Assistant Dean Clinical Trials
Washington University School of Medicine
Case Presentations 
Industry & Site Perspectives on Improving Contract Completion
Nancy Trapp
Clinical Operations Team Leader-Regulatory
Eli Lilly & Company

Clinical Research Management Taskforce
June 9, 2008
Meeting Materials

Clinical Research Management Taskforce meeting
May 12, 2008
Meeting Materials

Clinical Research Management Taskforce
April 14, 2008
Meeting Materials

Clinical Research Management Taskforce meeting
March 12, 2008
Meeting Materials

Clinical Research Management Taskforce
February 20, 2008
Meeting Materials

Clinical Research Management Taskforce
January 24, 2008
Meeting Materials